Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727904
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-02-06
Brief Title:
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma
Sponsor:
Organization:
Iovance Biotherapeutics Inc